Report
Debbie Wang
EUR 98.48 For Business Accounts Only

Becton Dickinson seeks to fold CR Bard under its umbrella.

With the announcement of Becton Dickinson’s agreement to purchase CR Bard, we plan to raise our fair value estimate to $317 per share, reflecting BD’s offer price. We think CR Bard shareholders are getting a pretty premium, at roughly 61% more than our intrinsic value.  At this point, we do not expect any substantive antitrust issues to derail this deal. We’ve long been fans of Bard’s strategy, which is focused on consumable products for hospitals that contribute to greater safety, better outcom...
Underlying
C. R. Bard Inc.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch